Next Article in Journal
Trends in the Prescription of Strong Opioids for Chronic Non-Cancer Pain in Primary Care in Catalonia: Opicat-Padris-Project
Next Article in Special Issue
Physiologically Based Pharmacokinetic Modelling and Simulation to Predict the Plasma Concentration Profile of Doxorubicin
Previous Article in Journal
Nanotechnology Driven Cancer Chemoradiation: Exploiting the Full Potential of Radiotherapy with a Unique Combination of Gold Nanoparticles and Bleomycin
Previous Article in Special Issue
In Silico Evaluation of Binding of 2-Deoxy-D-Glucose with Mpro of nCoV to Combat COVID-19
 
 
Article

Article Versions Notes

Pharmaceutics 2022, 14(2), 234; https://doi.org/10.3390/pharmaceutics14020234
Action Date Notes Link
article xml file uploaded 20 January 2022 09:19 CET Original file -
article xml uploaded. 20 January 2022 09:19 CET Update https://www.mdpi.com/1999-4923/14/2/234/xml
article pdf uploaded. 20 January 2022 09:19 CET Version of Record https://www.mdpi.com/1999-4923/14/2/234/pdf
article supplementary file uploaded. 20 January 2022 09:19 CET - https://www.mdpi.com/1999-4923/14/2/234#supplementary
article html file updated 20 January 2022 09:21 CET Original file -
article supplementary file uploaded. 21 January 2022 02:32 CET - https://www.mdpi.com/1999-4923/14/2/234#supplementary
article html file updated 21 January 2022 02:33 CET Update -
article html file updated 31 July 2022 04:51 CEST Update https://www.mdpi.com/1999-4923/14/2/234/html
Back to TopTop